Correction to: Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase (Archives of Pharmacal Research, (2018), 41, 2, (196-207), 10.1007/s12272-017-0999-6)

Md Yousof Ali; Hyun Ah Jung; Susoma Jannat; Jae Sue Choi

doi:10.1007/s12272-019-01113-4

Correction to: Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase (Archives of Pharmacal Research, (2018), 41, 2, (196-207), 10.1007/s12272-017-0999-6)

Md Yousof Ali
, Hyun Ah Jung
, Susoma Jannat
, Jae Sue Choi^*

^*Corresponding author for this work

Department of Food Science and Human Nutrition

Pukyong National University

Research output: Contribution to journal › Comment/debate

Abstract

The author would like to include conflict of interest statement of the online published article. The correct conflict of interest statement should read as: Conflict of interest The authors declare no conflict of interest.

Original language	English
Pages (from-to)	379
Number of pages	1
Journal	Archives of Pharmacal Research
Volume	42
Issue number	4
DOIs	https://doi.org/10.1007/s12272-019-01113-4
State	Published - 2019.04.1

Quacquarelli Symonds(QS) Subject Topics

Medicine
Engineering - Petroleum
Pharmacy & Pharmacology
Chemistry

Access to Document

10.1007/s12272-019-01113-4

Fingerprint

Dive into the research topics of 'Correction to: Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase (Archives of Pharmacal Research, (2018), 41, 2, (196-207), 10.1007/s12272-017-0999-6)'. Together they form a unique fingerprint.

Cite this

Ali, M. Y., Jung, H. A., Jannat, S., & Choi, J. S. (2019). Correction to: Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase (Archives of Pharmacal Research, (2018), 41, 2, (196-207), 10.1007/s12272-017-0999-6). Archives of Pharmacal Research, 42(4), 379. https://doi.org/10.1007/s12272-019-01113-4

Ali, Md Yousof ; Jung, Hyun Ah ; Jannat, Susoma et al. / Correction to : Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase (Archives of Pharmacal Research, (2018), 41, 2, (196-207), 10.1007/s12272-017-0999-6). In: Archives of Pharmacal Research. 2019 ; Vol. 42, No. 4. pp. 379.

@article{606e1c8250bc4bc9ab5bbe30f3bfac6c,

title = "Correction to: Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase (Archives of Pharmacal Research, (2018), 41, 2, (196-207), 10.1007/s12272-017-0999-6)",

abstract = "The author would like to include conflict of interest statement of the online published article. The correct conflict of interest statement should read as: Conflict of interest The authors declare no conflict of interest.",

author = "Ali, \{Md Yousof\} and Jung, \{Hyun Ah\} and Susoma Jannat and Choi, \{Jae Sue\}",

note = "Publisher Copyright: {\textcopyright} 2019, The Pharmaceutical Society of Korea.",

year = "2019",

month = apr,

day = "1",

doi = "10.1007/s12272-019-01113-4",

language = "English",

volume = "42",

pages = "379",

journal = "Archives of Pharmacal Research",

issn = "0253-6269",

number = "4",

}

Ali, MY, Jung, HA, Jannat, S & Choi, JS 2019, 'Correction to: Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase (Archives of Pharmacal Research, (2018), 41, 2, (196-207), 10.1007/s12272-017-0999-6)', Archives of Pharmacal Research, vol. 42, no. 4, pp. 379. https://doi.org/10.1007/s12272-019-01113-4

Correction to: Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase (Archives of Pharmacal Research, (2018), 41, 2, (196-207), 10.1007/s12272-017-0999-6). / Ali, Md Yousof; Jung, Hyun Ah; Jannat, Susoma et al.
In: Archives of Pharmacal Research, Vol. 42, No. 4, 01.04.2019, p. 379.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase (Archives of Pharmacal Research, (2018), 41, 2, (196-207), 10.1007/s12272-017-0999-6)

AU - Ali, Md Yousof

AU - Jung, Hyun Ah

AU - Jannat, Susoma

AU - Choi, Jae Sue

PY - 2019/4/1

Y1 - 2019/4/1

N2 - The author would like to include conflict of interest statement of the online published article. The correct conflict of interest statement should read as: Conflict of interest The authors declare no conflict of interest.

AB - The author would like to include conflict of interest statement of the online published article. The correct conflict of interest statement should read as: Conflict of interest The authors declare no conflict of interest.

UR - https://www.scopus.com/pages/publications/85060054535

U2 - 10.1007/s12272-019-01113-4

DO - 10.1007/s12272-019-01113-4

M3 - Comment/debate

C2 - 30637618

AN - SCOPUS:85060054535

SN - 0253-6269

VL - 42

SP - 379

JO - Archives of Pharmacal Research

JF - Archives of Pharmacal Research

IS - 4

ER -

Ali MY, Jung HA, Jannat S, Choi JS. Correction to: Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase (Archives of Pharmacal Research, (2018), 41, 2, (196-207), 10.1007/s12272-017-0999-6). Archives of Pharmacal Research. 2019 Apr 1;42(4):379. doi: 10.1007/s12272-019-01113-4

Correction to: Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase (Archives of Pharmacal Research, (2018), 41, 2, (196-207), 10.1007/s12272-017-0999-6)

Abstract

Quacquarelli Symonds(QS) Subject Topics

Access to Document

Other files and links

Fingerprint

Cite this